Pipeline · Bill → Law
Step 1
Introduced
Oct 6, 2023
Step 2
Referred
Oct 25, 2023
E&C
Step 3
Committee
Step 4
House floor
Step 5
Senate
Step 6
Resolve Changes
Step 7
Signed
SummaryCRS Summary
This bill requires the Food and Drug Administration (FDA) to hold a hearing and establish a task force on the health and safety of products with kratom (an herbal substance that produces opioid- and stimulant-like effects). It also prohibits the FDA from regulating kratom products in a manner that is more restrictive as compared to regulations for food, dietary supplements, or dietary ingredients.
Timeline · 3 actions
Oct 25, 2023
Referred to the Subcommittee on Health.
Oct 25, 2023
Referred to the House Committee on Energy and Commerce.
Oct 6, 2023
Introduced in House